Exact Mass: 649.1768518

Exact Mass Matches: 649.1768518

Found 29 metabolites which its exact mass value is equals to given mass value 649.1768518, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pyranodelphinin A

11-hydroxy-3-methyl-6-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-7-(3,4,5-trihydroxyphenyl)-2λ⁴,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1,3,5(13),6,9,11-hexaen-2-ylium

C30H33O16 (649.1768518)


Pyranodelphinin A is found in fruits. Pyranodelphinin A is a constituent of the seeds of Ribes nigrum (blackcurrant) Constituent of the seeds of Ribes nigrum (blackcurrant). Pyranodelphinin A is found in fruits.

   

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

C32H31N3O12 (649.1907646)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D064449 - Sequestering Agents > D002614 - Chelating Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Malvidin 3-caffeoyl-glucoside

3-{[(2S,3R,4S,5S,6R)-6-({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-(3-ethenyl-5-methoxy-4-methylphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C34H33O13 (649.1921068)


Malvidin 3-caffeoyl-glucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Malvidin 3-caffeoyl-glucoside can be found in common grape, which makes malvidin 3-caffeoyl-glucoside a potential biomarker for the consumption of this food product.

   

Cytidin-5-diphospho-6-deoxy-3C-methyl-2-O-methyl-4-O-(O-methylglycolyl)-L-aldohexopyranose|O5-[1,2-dihydroxy-2-(O4-methoxyacetyl-3,O2-dimethyl-beta-L-6-deoxy-talopyranosyloxy)-diphosphoryl]-cytidine

Cytidin-5-diphospho-6-deoxy-3C-methyl-2-O-methyl-4-O-(O-methylglycolyl)-L-aldohexopyranose|O5-[1,2-dihydroxy-2-(O4-methoxyacetyl-3,O2-dimethyl-beta-L-6-deoxy-talopyranosyloxy)-diphosphoryl]-cytidine

C20H33N3O17P2 (649.1285148000001)


   

2,2,2-triamino-4,4,4-trioxo-4,4,4-(12H,14H-benzo[5,6][1,4]thiazino[3,2-b]phenoxazine-1,11,13-triyl)-tris-butyric acid|Omarin

2,2,2-triamino-4,4,4-trioxo-4,4,4-(12H,14H-benzo[5,6][1,4]thiazino[3,2-b]phenoxazine-1,11,13-triyl)-tris-butyric acid|Omarin

C30H27N5O10S (649.1478562000001)


   

Raloxifene 6-glucuronide

Raloxifene-6-glucuronide

C34H35NO10S (649.198157)


   

Raloxifene-4-glucuronide

Raloxifene-4-glucuronide

C34H35NO10S (649.198157)


   

Pyranodelphinin A

11-hydroxy-7-methyl-4-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-3-(3,4,5-trihydroxyphenyl)-2$l^{4},8-dioxatricyclo[7.3.1.0^{5,13}]trideca-1(12),2,4,6,9(13),10-hexaen-2-ylium

C30H33O16 (649.1768518)


   

UNII:73033I28Y6

Mosapride citrate dihydrate

C27H37ClFN3O12 (649.2049684000001)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents

   

Cefbuperazone sodium

Cefbuperazone sodium

C22H28N9NaO9S2 (649.1349038000001)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002513 - Cephamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

PF 3084014 hydrobromide

PF 3084014 hydrobromide

C27H43Br2F2N5O (649.1802211999999)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

[[(2R,3S,4R,5R)-5-[3-(aminomethyl)pyridin-1-ium-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate

[[(2R,3S,4R,5R)-5-[3-(aminomethyl)pyridin-1-ium-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate

C21H29N7O13P2 (649.1298524)


   

[7-Methyl-3-(3,4,5-trihydroxyphenyl)-4-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium

[7-Methyl-3-(3,4,5-trihydroxyphenyl)-4-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium

C30H33O16+ (649.1768518)


   

Malvidin 3-caffeoyl-glucoside

Malvidin 3-caffeoyl-glucoside

C34H33O13+ (649.1921068)


   
   

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

C23H39NO20 (649.2065334)


alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp in which the anomeric configuration of the reducing-end glucose is beta.

   

gamma-aminooctyl-GTP

gamma-aminooctyl-GTP

C18H34N7O13P3 (649.1427384)


A nucleoside triphosphate analogue that is GTP in which one of the OH groups at the gamma-position of the triphosphate is replaced by an 8-aminooctylamino group.

   

alpha-Neu5Gc-(2->6)-beta-Gal-(1->4)-Glc

alpha-Neu5Gc-(2->6)-beta-Gal-(1->4)-Glc

C23H39NO20 (649.2065334)


   
   

NeuGc(a2-3)[Gal(b1-4)]Gal

NeuGc(a2-3)[Gal(b1-4)]Gal

C23H39NO20 (649.2065334)


   

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose

C23H39NO20 (649.2065334)


   

NeuGc(a2-6)Gal(b1-4)b-Glc

NeuGc(a2-6)Gal(b1-4)b-Glc

C23H39NO20 (649.2065334)


   

NeuGc(a2-3)[Gal(b1-4)]a-Gal

NeuGc(a2-3)[Gal(b1-4)]a-Gal

C23H39NO20 (649.2065334)


   

NeuGc(a2-3)[Gal(b1-4)]b-Gal

NeuGc(a2-3)[Gal(b1-4)]b-Gal

C23H39NO20 (649.2065334)


   

Indo 1

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

C32H31N3O12 (649.1907646)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D064449 - Sequestering Agents > D002614 - Chelating Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

C23H39NO20 (649.2065334)


An amino trisaccharide consisting of an N-glycoloylneuraminosyl residue linked alpha(2->3) to a lactose moiety.

   

FASN-IN-4 (tosylate)

FASN-IN-4 (tosylate)

C33H35N3O7S2 (649.191632)


FASN-IN-4 tosylate is a potent inhibitor of fatty acid synthase (FASN) with an IC50 of 10 nM (WO2012064642A1, compound 29)[1]. FASN-IN-4 tosylate also inhibits SARS-CoV-2 with an EC50 of 18.6?nM[2].